Li Li
Founder bij SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Vermogen: 686 M $ op 31-03-2024
Profiel
Li Li is een zakenman die Shenzhen Hepalink Pharmaceutical Group Co., Ltd. heeft opgericht en aan het hoofd heeft gestaan van 5 verschillende bedrijven. Momenteel is hij voorzitter van Shenzhen Techdow Pharmaceutical Co., Ltd. en voorzitter van Shenzhen Hepalink Pharmaceutical Group Co., Ltd., voorzitter & Chief Executive Officer van Hepalink USA, Inc. en voorzitter van Shenzhen Duopule Industrial Development Co., Ltd. (beide zijn dochterondernemingen van Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). (beide zijn dochterondernemingen van Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). Hij zetelt eveneens in de raad van bestuur van Cytovance Biologics, Inc. (voormalig voorzitter), Shenzhen Leren Technology Co. Ltd. en Urumqi Feilaishi Equity Investment Co. Ltd. De heer Li behaalde een bachelorgraad aan de Universiteit van Sichuan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 514 349 899 ( 41.24% ) | 594 M $ | 31-03-2024 | |
HIGHTIDE THERAPEUTICS INC
23.61% | 02-02-2024 | 121 515 210 ( 23.61% ) | 92 M $ | 31-03-2024 |
Actieve functies van Li Li
| Bedrijven | Functie | Begin |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21-04-1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Director/Board Member | - |
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Chairman | 13-01-2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director/Board Member | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
Eerdere bekende functies van Li Li
| Bedrijven | Functie | Einde |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02-02-2024 |
Opleiding van Li Li
| Sichuan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Technology Services |
| Urumqi Feilaishi Equity Investment Co. Ltd. | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
